Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-11 · accession 0000950170-25-084893 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-06-11 | 2025-06-11 | KYMR | Ridloff Elena | Dir | S - Sale+OE | $50.00 | -4,500 | 0 | -100% | -$225.0K |
| DT | 2025-06-11 | 2025-06-11 | KYMR | Ridloff Elena | Dir | M - OptEx | $20.29 | +4,500 | 4,500 | New | +$91.3K |
| DT | 2025-06-11 | 2025-06-11 | KYMR | Ridloff Elena | Dir | M - OptEx | $0.00 | -4,500 | 4,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-11 | S | D | 4,500 | $50.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-11 | M | A | 4,500 | $20.29 | 4,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-06-11 | M | D | 4,500 | $0.00 | 4,500 | D | $20.29 · — to 2032-06-29 | 4,500 Common Stock | (F2) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following the vesting commencement date of June 29, 2022, subject to the reporting person's continued service relationship through each vesting date. |